Head-to-head · WeighScore
PlushCare vs Sprout Health
The verdict
Sprout Health takes it — 79.8/100 to 74.5/100.
Sprout Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A LegitScript-certified desk that pairs low-cost compounded semaglutide and tirzepatide with a real brand-name Wegovy and Zepbound path — and a near-frictionless, often visit-free start.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | PlushCare | Sprout Health |
|---|---|---|
| WeighScore | 74.5/100 | 79.8/100 |
| Grade | C | C+ |
| Site position | #68 | #26 |
| Semaglutide | Varies (branded prescription; visits and advertised membership separate) | $299/mo |
| Tirzepatide | Varies (branded prescription; visits and advertised membership separate) | $349/mo |
| Coverage | All 50 states | Not disclosed |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #68 · C
Strengths
- Available in all 50 states
- Video appointments with primary care physicians
- Prescriptions can be sent to a pharmacy you choose
- Visit insurance and medication prior-authorization assistance offered; coverage depends on the plan
Where it loses points
- Advertised membership is $19.99 monthly after the first free month or $149 annually prepaid; visits, drugs and labs are separate
- Terms say membership is optional for medical services, while general FAQ implies active membership; confirm the nonmember booking route
- Cancel at least one calendar day before membership renewal; a visit can be nonrefundable after clinical assessment even without a prescription
Site position #26 · C+
FDAWarning letter issued to Sprout Health Partners LLC dba Sprout Health in September 2025. See the FDA warning-letter database.
Strengths
- LegitScript-certified with a listed address and contact line
- Both compounded ($149 semaglutide / $199 tirzepatide) and a genuine brand-name Wegovy/Zepbound route
- Low-friction intake — no labs and often no telehealth visit required
Where it loses points
- Compounded semaglutide and tirzepatide are not FDA-approved
- No oral or sublingual route — injectable only
- Thin transparency — no named medical director, and state availability is quiz-gated
- "No labs, no visit" convenience also means lighter clinical oversight
Featured provider
Sprout Health
Sprout Health scores 79.8/100 (C+). A LegitScript-certified desk that pairs low-cost compounded semaglutide and tirzepatide with a real brand-name Wegovy and Zepbound path — and a near-frictionless, often visit-free start.
Commercial relationships affect this placement. The score comparison above is separate.
FDAWarning letter issued to Sprout Health Partners LLC dba Sprout Health in September 2025. See the FDA warning-letter database.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.